Through the lncRNA PVT1-miR-16-5p/VEGFA/VEGFR1/AKT axis, lncRNA PVT1 is directly involved in the progression of CRC and is a potential target for CRC treatment. This evidence concerns the gene PVT1 and colorectal carcinoma.